Interleukin-8 (IL-8) is a neutrophil chemotactic and activating cytokine that is produced in response to several stimuli. Because monocytic cells are important producers of IL-8, we investigated whether interferon-7 (IFN-T), a potent inducer of activation and differentiation of mononuclear phagocytes, affected IL-8 expression in this cell lineage. We found a low constitutive level of IL-8 mRNA expression that was upregulated by IFN-7 in a dose-and time-dependent manner and via a protein-synthesis-dependent process in the human monocytic cell line U937. IL-8 protein secretion was also stimulated by IFN-7. Nuclear run-on ex- , originally described as a neutrophil chemotactic and activating cytokine,l*6 also possesses chemotactic activity for basophils and T lymphocytes, both in vitro and in Monocytic cells seem to be the predominant source of IL-8,1,2,9 although a wide variety of cells, including fibroblasts,IO,'' endothelial and epithelial cell^,'^"^ keratinocytes,1°,'5 condrocytes,L6 lymphocytes," and human tumor cell lines18x19 can express IL-8 mRNA and produce the protein in response to tumor necrosis factor-a (TNF-(U), IL-l ,10313,18 mitogens, lectins, and viruses. The human promonocytic leukemia line U93735 responds to IFN--, with decreased proliferation and the expression of Ig-Fc receptors (FcRs) and HLA-DR antigens, as well as antibody-dependent cellular cytotoxicity and hydrogen peroxide production.36-38 IFN--, exerts opposite effects on IL-8 gene expression and/or protein secretion depending on the lineage of the target cells. Inhibitory effects of IFN--, on IL-8 were reported in fib rob last^^^ and thymic epithelial cells,@ whereas enhancing activity has been shown in keratino~ytes'~ and human gastric cancer cell lines." Because monocytic cells can respond to IFN--, and they are important producers of IL-8, it was of interest to establish whether IFN--, could affect IL-8 expression in this cell lineage. In this report, we show that IFN--, is an inducer of IL-8 mRNA accumulation and protein secretion by the monocytic cell line U937, and that this induction occurs via a protein-synthesis-dependent process. Furthermore, we show that the enhancement of IL-8 mRNA expression by IFN-y is controlled primarily at a posttranscriptional level.
NTERLEUKIN-8 (IL-8), originally described as a neutrophil chemotactic and activating cytokine,l*6 also possesses chemotactic activity for basophils and T lymphocytes, both in vitro and in Monocytic cells seem to be the predominant source of IL-8,1,2,9 although a wide variety of cells, including fibroblasts,IO,'' endothelial and epithelial cell^,'^"^ keratinocytes,1°,'5 condrocytes,L6 lymphocytes," and human tumor cell lines18x19 can express IL-8 mRNA and produce the protein in response to tumor necrosis factor-a (TNF-(U), IL-l ,10313,18 mitogens, lectins, and viruses. 13,20 IFN--, is a product of activated T lymphocytes and natural killer cells with antiproliferative, antiviral and immunomodulatory properties.21 This cytokine is a potent inducer of activation and differentiation of mononuclear phagoc y t e~,~~,~~ manifested by increase in class I1 HLA antig e n~~~,~~ and transferrin receptor expression,26 toxic oxygen derivatives and nitric oxide p r o d~c t i o n ,~"~~ tumoricidal activity,22,28 and regulation of cytokine p r o d~c t i o n .~~,~~-~~ IFN--, is inhibitory for normal myelopoie~is~~ and for the in vitro growth of myeloid and monocytoid human leukemia cell lines.33 Upon exposure to IFN-7, normal and leukemic promyelocytic and promonocytic cells differentiate in vitro along the monocytic The human promonocytic leukemia line U93735 responds to IFN--, with decreased proliferation and the expression of Ig-Fc receptors (FcRs) and HLA-DR antigens, as well as antibody-dependent cellular cytotoxicity and hydrogen peroxide production. [36] [37] [38] IFN--, exerts opposite effects on IL-8 gene expression and/or protein secretion depending on the lineage of the target cells. Inhibitory effects of IFN--, on IL-8 were reported in fib rob last^^^ and thymic epithelial cells,@ whereas enhancing activity has been shown in keratino~ytes'~ and human gastric cancer cell lines." Because monocytic cells can respond to IFN--, and they are important producers of IL-8, it was of interest to establish whether IFN--, could affect IL-8 expression in this cell lineage. In this report, we show that IFN--, is an inducer of IL-8 mRNA accumulation and protein secretion by the monocytic cell line U937, and that this induction occurs via a protein-synthesis-dependent process. Furthermore, we show that the enhancement of IL-8 mRNA expression by IFN-y is controlled primarily at a posttranscriptional level.
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MATERIALS AND METHODS
Cell culture. The human promonocytic cell line U937, oripinally established from a patient with histiocytic lymphoma,3s was cultured at 37'C in a 5% CO2-humidified atmosphere in RPM1 1640 (Advanced Biotechnology, Columbia, MD), supplemented with 100 U/mL penicillin, 100 U/mL streptomycin, 2 mmol/L glutamine, and 10% heat-inactivated fetal calf serum (FCS) (HyClone Laboratories, Logan, UT), hereafter referred to as complete medium (CM). Exponentially growing cells were centrifuged, resuspended at a concentration of 8 X lo5 cells/mL of medium, and plated in 15-cm Lux plates (Miles Scientific, Wapersville, CA) in fresh CM alone or supplemented with the indicated doses of recombinant human IFN-7 (specific activity 2.02 X IO' U/mg), kindly provided by Dr Creig Reynolds (BRMP, National Cancer InstituteFrederick Cancer Research and Development Center, Frederick, MD). Cells and supernatants were harvested at predetermined times and spun at 1,400 rpm for 5 minutes. Cell-free supernatants were collected and tested for cytokme release; cell pellets were extracted for total RNA. For mRNA-synthesis inhibition, actinomycin D (DAct; Sigma Chemical CO, St Louis, MO) was dissolved in ethanol at I mg/mL and used at a final concentration of 5 pg/mL for the times specified in the text. For protein-synthesis inhibition experiments, cycloheximide (Sigma) was used at 10 pg/mL final concentration. All the reagents were demonstrated by the Limulus amebocyte test (MA Bioproducts, Walkersville, MD; sensitivity 0.06 EU/mL) to be endotoxin free.
Northern blot analysis. Cells were lysed in RNAzol (Tel-Test, Inc, Friendswood, TX) and total RNA was purified according to the manufacturer's instructions. Twenty micrograms of total RNA from each sample was electrophoresed under denaturing conditions on a 1.2% agarose gel containing 2.2 mol/L formaldehyde, trans- 
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added in I mL of Hybrizol (Oncor) to Nytran membranes on which 5 pg of linearized plasmid containing the full-length IL-8 cDNA. chicken @-actin ( I .8 kb Nindlll fragment), and Hindlll linearized pUC19 were immobilized usingaslot blot apparatus(GIBC0-BRL, Gaithersburg, MD). Hybridization was performed at 42'C for 40 hours, and filters were then washed as described for Northern analysis before an additional washing was performed for 15 minutes at room temperature in 2X SSC containing 1 pglmL of RNase A (Boehringer). Filters were then exposed for autoradiography.
RESULTS
IL-8 mRNA e,rpre.mion and cytokine prodwtion. To determine whether the U937 cell line responded to IFN-r with ferred onto Nytran membranes (Schleicher & Schuell Inc. Keene, NH), and cross-linked by UV irradiation, as previously described.23 Filters were prehybridized for 6 hours at 42°C in Hybrisol solution (Oncor Inc. Gaithersburg. MD) and hybridized overnight with 2 X IO6 cpm/mL of 32P-labeled probe. Membranes were then washed three times at room temperature for IO minutes in 2X SSC, 0.1% sodium dodecyl sulfate (SDS) and twice at 60°C for I5 minutes in 0.2X SSC. 0. l% SDS. before being autoradiographed using Kodak X A R J film (Eastman Kodak, Rochester, NY) and intensifying screens at -80°C. Probes were labeled by random priming reaction using a commercial kit (Boehringer Mannheim Biochemicals. Indianapolis, IN) and [d2P]dCTP (3,000 Ci/mmol: Amersham Corp. Arlington Heights, IL). The specific activity was always higher than IO9 cpmlpg. For IL-8 detection. the IL-8 full-length cDNA, kindly provided by Dr K. Matsushima (Kanazawa University Cancer Institute, Kanazawa, Ishikawa-ken. Japan). was used; glyceraldehyde-3 phosphate dehydrogenase mRNA levels were assessed by using the human G3PDH probe from Clontech (Palo Alto, CA). When needed, the autoradiographs were scanned using a light densitometer. Cytokine determination. IL-8 release from U937 cells was determined by enzyme-linked immunosorbent assay (ELISA; Amersham), that allows detection of IL-8 concentration above 30 pg/mL.
Nuclear run-on. Nuclear run-on experiments were performed as previously described.23 Briefly, nuclei were isolated from 5 X IO' cells/sample by lysis in 4 mL of lysis buffer ( I O mmol/L Tris-Cl. U/mL of IFN-y. A significant and maximal increase in IL-8 mRNA above the steady-state level was observed at 18 hours and 24 hours of stimulation, gradually decreasing thereafter (Fig 2) . In conclusion, these results provide clear evidence that IFN-y can upregulate IL-8 mRNA expression in cells of the monocytic lineage.
To investigate whether the induction of IL-8 mRNA was associated with cytokine secretion, supernatants from cultured cells were harvested at various times after stimulation with 250 U/mL of IFN-y and assayed for IL-8 protein levels by ELISA. Levels of secreted IL-8 rapidly increased between 12 and 36 hours in response to stimulation, reaching a plateau by 36 hours (Fig 3) . We conclude that IL-8 mRNA accumulation is associated with IL-8 secretion. To assess the possibility that induction of IL-8 accumulation by IFN-y was the result of mRNA stabilization, the half-life of IL-8 mRNA was measured. U937 cells were incubated for 18 hours with medium alone or supplemented with 250 U/mL of IFN-y and treated with 5 ccg/mL of DAct for various lengths of time to block further RNA transcrip tion. We found that IL-8 mRNA decayed with different kinetics in untreated and treated cells after the inhibition of RNA synthesis (Fig 5) . In fact, the levels of IL-8 mRNA in medium-treated cells were already decreased by about 50% after 40 minutes of exposure to DAct, and became almost undetectable after 6 hours (TlI2 40 minutes). IFN-y treatment increased the stability of IL-8 mRNA threefold (T1/2 120 minutes). Similar differences in the half-life of IL-8 mRNA were observed in three independent experiments. These results indicated that the enhancement of IL-8 mRNA by IFN-y was associated with the stabilization ofthe mRNA.
Control
To determine the requirement for active protein synthesis in IL-8 mRNA induction by IFN-y, U937 cells were incubated for 18 hours with 250 U/mL of IFN-y in the presence or absence of the protein-synthesis inhibitor cycloheximide (CHX; IO pg/mL). As depicted by the results shown in 
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IL-8 mRNA decayed at a slower rate in IFN-y-treated than in medium-treated cells. These findings indicate that IFN-y enhanced the stability of IL-8 mRNA and that this effect may account for, or at least contribute to, the augmentation of IL-8 mRNA levels. The inhibition of IFN-y stimulatory effects by a protein-synthesis inhibitor shows requirement for de novo protein synthesis and suggests that IFN-y-inducible proteins may contribute to IL-8 mRNA stabilization. Posttranscriptional control of gene expression by IFNy has been previously shown in murine, peritoneal macrophages.48349 Furthermore, our data support a previous observation of regulation of IL-8 mRNA induction at the posttranscriptional level in PMA-stimulated HL60 promyelocyte~~' and indicate that IL-8 gene expression can be controlled by different molecular regulatory mechanisms in a cell-type specific manner, even if the cells are exposed to the same stimulus.
